Summary
The effect of phenobarbital treatment on bilirubin metabolism and bile secretion was studied in a patient with Crigler-Najjar syndrome, type II and acquired cholestasis. Following cholecystectomy and choledochostomy, a balloon inflatable T tube was inserted to facilitate bile collection. Hepatic UDP-glucuronyltransferase in surgically obtained liver tissue was 25% of normal activity and bilirubin monoconjugates accounted for >80% of the pigments in bile. Phenobarbital therapy decreased the concentration of fasting serum bile acids by 33% and partially reestablished their enterohepatic cycling postprandially. The total fasting serum bilirubin concentration (>90% unconjugated) increased 21% during phenobarbital treatment and was unaffected by caloric intake. Bile flow was increased 2.7 times after phenobarbital treatment. The biliary concentration of total bilirubin was increased 2.4 times, primarily due to monoconjugated bilirubin, which accounted for 91% of the biliary pigments. Bile acid, phospholipid, cholesterol, and calcium concentrations in bile were significantly increased after phenobarbital. The data indicate that even in the presence of cholestasis an underlying deficiency in bilirubin conjugation may be confirmed by biliary pigment analysis.
Similar content being viewed by others
References
Arias IM, Gartner LM, Cohen M, Ezzer JB, Levi AJ, et al: Chronic nonhemolytic unconjugated hyperbilirubinemia with glucuronyl transferase deficiency. Am J Med 47:395–409, 1969
Berthelot P, Dhumeaux D: New insights into the classification and mechanism of hereditary, chronic, nonhaemolytic hyperbilirubinemia. Gut 19:474–480, 1978
Gordon ER, Shaffer EA, Sass-Kortsak A: Bilirubin secretion and conjugation in the Crigler-Najjar syndrome type II. Gastroenterology 70:761–765, 1976
Gollan JL, Huang SN, Billing B, Sherlock S: Prolonged survival in three brothers with severe type 2 Crigler-Najjar syndrome. Gastroenterology 68:1543–1555, 1975
Capron JP, Erlinger S: Barbiturates and biliary function. Digestion 12:43–56, 1975
Stiehl A, Thaler MM, Admirand WH: The effects of phenobarbital on bile salts and bilirubin in patients with intrahepatic and extrahepatic cholestasis. N Engl J Med 286:858–861, 1972
Bloomer JR, Boyer JL: Phenobarbital effects in cholestatic liver disease. Ann Intern Med 82:310–317, 1975
Sharp HL, Mirkin BL: Effect of phenobarbital in hyperbilirubinemia, bile acid metabolism, and microsomal enzyme activity in chronic intrahepatic cholestasis of childhood. J Pediatr 81:116–126, 1972
Soloway RD, Carlson HC, Shoenfield LJ: A balloon-occludable T-tube for cholangiography and quantitative collection and reinfusion of bile in man. J Lab Clin Med 79:500–504, 1972
Committee on Dietetics of the Mayo Clinic: Mayo Clinic Diet Manual 1971, 4th ed. Phildelphia, WB Saunders Co
Heirwegh KPM, Fevery J, Meuwissen JATP, DeGroote J: Recent advances in the separation and analysis of diazopositive bile pigments. Methods Biochem Anal 22:205–250, 1974
Trotman BW, Roy-Chowdhury J, Wirt GD, Bernstein SE: Azodipyrroles of unconjugated and conjugated bilirubin using diazotized ethyl anthranilate in dimethyl sulfoxide. Anal Biochem 121:175–180, 1982
Ostrow JD, Murphy NH: Isolation and properties of conjugated bilirubin from bile. Biochem J 120:311–327, 1970
Fevery J, Verwilghen R, Tan TG, DeGroote J: Glucuronidation of bilirubin and the occurrence of pigment gallstones in patients with chronic hemolytic diseases. Eur J Clin Invest 10:219–226, 1980
Talalay P: Enzymatic analysis of steroid hormones. Methods Biochem Anal 8:119–143, 1960
Fiske CH, Subbarrow Y: the colorimetric determination of phosphorus. J Biol Chem 66:375–400, 1925
Abell LL, Levy BB, Brodie BB, Kendall FE: A simplified method for the estimation of total cholesterol in serum and demonstration of its specificity. J Biol Chem 195:357–366, 1952
Trotman BW, Morris TA III, Sanchez HM, Soloway RD, Ostrow JD: Pigment versus cholesterol cholelithiasis: identification and quantification by infrared spectroscopy. Gastroenterology 72:495–498, 1977
Siskos PA, Cahill PT, Javitt NB: Serum bile acid analysis: A rapid direct enzymatic method using dual-beam spectrophotofluorimetry. J Lipid Res 18:666–671, 1977
Michaelsson M: Bilirubin determinations in serum and urine. Scand J Clin Lab Invest Suppl 56:40–50, 1961
Ellman GL, Courtney KD, Andres V Jr, Featherstone RM: A new and rapid colorometric determination of acetylcholinesterase activity. Biochem Pharmacol 7:88–95, 1961
Schmidt E: Glutamate dehydrogenase, UV assay.In Methods of Enzymatic Analysis. HU Bergmeyer (ed). New York, Academic Press, 1974 pp 650–656
Schmidt E: Strategy and evaluation of enzyme determinations in serum in disease of the liver and the biliary system.In Evaluation of Liver Function. LM Demers, LM Shaw (eds). Baltimore, Urban and Schwarzenberg 1978, pp 79–101
Orcutt J, Kozak P, Gillman S, Cummins LH: Micro-scale method for theophylline in body fluids by reverse-phase, high pressure liquid chromatography. Clin Chem 23:599–601, 1977
Black M, Billing BH, Heirwegh KPM: Determination of bilirubin UDP-glucuronyl transferase activity in needle biopsy specimens of human liver. Clin Chim Acta 29:27–35, 1970
Croxton E: Elementary Statistics: With Applications in Medicine and Biological Sciences. New York, Dover Publications, 1959, pp 1–376
Roy-Chowdhury J, Roy-Chowdhury N, Wu G, Shouval R, Arias IM: Bilirubin mono- and diglucuronide formation by human liverin vitro: Assay by high-pressure liquid chromatography. Hepatology 1:622–627, 1981
Rundle FF, Cass MH, Robson B, Middleton M: Biliary drainage after choledochostomy in man, with some observation on biliary fistula. Surgery 37:903–910, 1955
Soloway RD, Schoenfield LJ: Effects of meals and interruption of enterohepatic circulation on flow lipid composition, and cholesterol saturation in man after cholecystectomy. Am J Dig Dis 20:99–109, 1975
Goresky CA, Gordon ER, Shaffer EA, Pare P, Carassavas D, Aronoff A: Definition of a conjugation dysfunction in Gilbert's syndrome: Studies of the handling of bilirubin loads and of the pattern of bilirubin conjugates secreted in bile. Clin Sci Mol Med 55:63–71, 1978
Black M, Sherlock S: Treatment of Gilbert's syndrome with phenobarbitone. Lancet 1:1359–1361, 1970
DeBarros SG, Balistreri WF, Soloway RD, Weiss SG, Miller PC, Soper K: Response of total and individual serum bile acids to endogenous and exogenous bile acid input into the enterohepatic circulation. Gastroenterology 82:647–652, 1982
Barrett PVD: Effects of caloric and noncaloric materials in fasting hyperbilirubinemia. Gastroenterology 68:361–369, 1975
Fevery J, Blanckaert N, Heirwegh KPM, Preaux A-M, Berthelot P: Unconjugated bilirubin and an increased proportion of bilirubin monoconjugates in bile of patients with Gilbert's syndrome and Crigler-Najjar disease. J Clin Invest 60:970–979, 1977
Fevery J, Van Damme B, Michiels R, DeGroote J, Heirwegh KPM: Bilirubin conjugates in bile of man and rat in the normal state and in liver disease. J Clin Invest 51:2482–2492, 1972
Blitzer BL, Boyer JL: Cellular mechanisms of bile formation. Gastroenterology 82:346–357, 1982
Desmond PV, Patwardhan RV, Johnson RF, Schenker S: Impaired elimination of caffeine in cirrhosis. Dig Dis Sci 25:193–197, 1980
Parsons WD, Neims AH: Effect of smoking on caffeine clearance. Clin Pharmacol Ther 24:40–45, 1978
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Trotman, B.W., Shaw, L., Roy-Chowdhury, J. et al. Effect of phenobarbital on serum and biliary parameters in a patient with Crigler-Najjar syndrome, type II and acquired cholestasis. Digest Dis Sci 28, 753–762 (1983). https://doi.org/10.1007/BF01312568
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01312568